3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Blood Specimen Collection
53
Surveys and Questionnaires
30
Drug Therapy
27
Immunotherapy
25
Surgical Procedures, Operative
22
Carboplatin
22
Nivolumab
21
Immune Checkpoint Inhibitors
20
pembrolizumab
18
osimertinib
18
atezolizumab
17
Observation
17
Radiotherapy
16
Bevacizumab
15
Cisplatin
14
Afatinib
14
Specimen Handling
13
Gene Expression Profiling
13
Erlotinib Hydrochloride
13
lorlatinib
12
Pemetrexed
12
Magnetic Resonance Spectroscopy
11
Ipilimumab
11
Immunohistochemistry
11
Biopsy
11
durvalumab
10
alectinib
10
Paclitaxel
10
Bronchoscopy
10
Tomography, X-Ray Computed
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Blood Component Removal
×
Thoracic
×
Clear all
NCT04981119
2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled